XBIO
Xenetic Biosciences·NASDAQ
--
--(--)
--
--(--)
3.41 / 10
Netural
Xenetic Biosciences presents poor fundamentals (score 3.4/10). Key concerns include Days sales outstanding at 72.5 days (score 1) and a negative Revenue-MV factor (-0.36, score 3). Conversely, Interest coverage ratio (EBIT/Interest expense) of 15.5 earns a score of 2, while Asset-MV (-0.50, score 2) and Profit-MV (0.46, score 2) offer moderate support. The composite score of 3.4 suggests limited intrinsic value and a defensive investment view is advisable.
Analysis Checks(8/10)
Revenue-MV
Value-0.36
Score3/3
Weight18.84%
1M Return10.54%
Value-0.36
Score3/3
Weight18.84%
1M Return10.54%
Days sales outstanding
Value72.55
Score1/3
Weight-2.07%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.07%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight15.04%
1M Return8.45%
Value-0.17
Score2/3
Weight15.04%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.50%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.50%
1M Return-1.11%
Asset-MV
Value-0.50
Score2/3
Weight19.37%
1M Return10.15%
Value-0.50
Score2/3
Weight19.37%
1M Return10.15%
Total operating revenue (YoY growth rate %)
Value19.37
Score2/3
Weight1.61%
1M Return1.11%
Value19.37
Score2/3
Weight1.61%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight15.02%
1M Return8.45%
Value0.46
Score2/3
Weight15.02%
1M Return8.45%
PB-ROE
Value-0.10
Score1/3
Weight18.29%
1M Return9.57%
Value-0.10
Score1/3
Weight18.29%
1M Return9.57%
Operating revenue (YoY growth rate %)
Value19.37
Score2/3
Weight0.62%
1M Return0.43%
Value19.37
Score2/3
Weight0.62%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight14.77%
1M Return8.41%
Value-0.07
Score2/3
Weight14.77%
1M Return8.41%
Revenue-MV
Value-0.36
Score3/3
Weight18.84%
1M Return10.54%
Value-0.36
Score3/3
Weight18.84%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value19.37
Score2/3
Weight1.61%
1M Return1.11%
Value19.37
Score2/3
Weight1.61%
1M Return1.11%
Days sales outstanding
Value72.55
Score1/3
Weight-2.07%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.07%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight15.02%
1M Return8.45%
Value0.46
Score2/3
Weight15.02%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight15.04%
1M Return8.45%
Value-0.17
Score2/3
Weight15.04%
1M Return8.45%
PB-ROE
Value-0.10
Score1/3
Weight18.29%
1M Return9.57%
Value-0.10
Score1/3
Weight18.29%
1M Return9.57%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.50%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.50%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value19.37
Score2/3
Weight0.62%
1M Return0.43%
Value19.37
Score2/3
Weight0.62%
1M Return0.43%
Asset-MV
Value-0.50
Score2/3
Weight19.37%
1M Return10.15%
Value-0.50
Score2/3
Weight19.37%
1M Return10.15%
Cash-MV
Value-0.07
Score2/3
Weight14.77%
1M Return8.41%
Value-0.07
Score2/3
Weight14.77%
1M Return8.41%
Is XBIO undervalued or overvalued?
- XBIO scores 3.41/10 on fundamentals and holds a Fair valuation at present. Backed by its -42.19% ROE, -110.40% net margin, -1.55 P/E ratio, 1.20 P/B ratio, and 23.31% earnings growth, these metrics solidify its Netural investment rating.
